ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates
ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates GlobeNewswire November 10, 2025 Full results from the Phase 2 REGEN-007 study of rilparencel were recently presented as a late-breaking clinical trial at the American Society of Nephrology (ASN) Kidney Week 2025 More than half of the patients required for the Phase […]